Senior Analyst, Investment Team (Life Science Tools & Services)

### ABOUT ARCHIMED With offices in Europe, the US and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare. Our mix of operational, medical, scientific and financial expertise positions us as both a strategic and financial partner to healthcare businesses. Priority areas include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools and Biologic Services, MedTech and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages $11 billion across its funds, including the largest healthcare-only private equity fund raised by a European-based GP. MED I, MED II and MED Platform I are all top-decile performers for their vintage according to Preqin data. Since inception, ARCHIMED has been a committed impact investor, both directly and through its EURÊKA Foundation. ### THE TEAM An global team with complementary backgrounds across investment, medical, scientific, strategic and operational disciplines. Alumni of INSEAD, Wharton, Berkeley, Georgetown, Bocconi, HEC Paris, École des Ponts ParisTech, ESSEC, Imperial College and Dartmouth, among others. Professional backgrounds spanning Private Equity (3i, Siparex, USS Ltd, Barings, Capiton, Partners Group, KKR), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC, Goldman Sachs, Jefferies) and Industry (Biotronik, Cerba, Stryker, Phillips, Pfizer, Baxter, LivaNova, J&J, Galderma, Sanofi). ### THE LIFE SCIENCES TOOLS & SERVICES TEAM The Life Sciences Tools & Services team invests behind the businesses that underpin pharma, biotech and diagnostics end markets, including instruments, consumables, reagents, bioprocessing, CRO and CDMO services, and specialized lab and analytical services. The team combines deep sector conviction with disciplined execution, backing category leaders and building them through internationalization, innovation and acquisition. ### THE ROLE The Senior Analyst will sit within the Life Sciences Tools & Services investment team and support the full investment lifecycle, from origination and diligence through execution and portfolio value creation. Reporting to the team's Vice Presidents and Principals and working directly with Partners, the Senior Analyst will own core analytical workstreams and carry direct responsibility for the financial modeling, market analysis and diligence output that inform the firm's investment decisions. This is a high-ownership seat for a commercial, intellectually curious analyst who wants to develop genuine sector expertise and a durable investing skill set inside a focused, performance-driven team. - **Investment Analysis & Financial Modeling** - Build and maintain detailed operating models, LBO models and returns analyses to evaluate new investments, add-on acquisitions and portfolio scenarios. - Develop valuation frameworks across DCF, trading and transaction comparables, and assess capital structure, sources and uses, and sensitivity outcomes. - Translate diligence findings into clear, decision-ready outputs that frame the investment thesis, key risks and the path to returns. - **Due Diligence & Execution** - Run commercial, financial and operational diligence workstreams in coordination with external advisors, deal counsel and management teams. - Synthesize data rooms, expert calls and third-party reports into concise findings that sharpen the team's view on each opportunity. - Draft investment committee memoranda, management presentations and term sheet inputs to a standard that withstands senior scrutiny. - **Sourcing, Research & Thesis Development** - Map sub-sectors across the tools and services landscape, identify attractive niches and build the target pipeline that supports proactive origination. - Produce thematic and competitive research that anticipates structural shifts in end markets, technology and the funding environment. - Track relevant deal activity, valuations and…